Transthyretin Amyloidosis
Pipeline by Development Stage
Drug Modality Breakdown
Competitive Landscape
8 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Clinical Trials (8)
Total enrollment: 2,515 patients across 8 trials
Evuzamitide in PET/CT to Measure Potential Therapeutic Response in ATTR
Evaluation of a Claims-based Algorithm for the Identification of Transthyretin-mediated Amyloidosis (ATTR) Amyloidosis in Medical Records
Short-term Effects of TOLCAPONE on Transthyretin Stability in Subjects With Leptomeningeal TTR Amyloidosis (ATTR)
The Eplontersen Pregnancy and Lactation Outcomes Study
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
Phenotyping and Characterization of wtATTR-CM (TRACE 1)
Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF
Biomarker for Transthyretin-Related Familial Amyloidotic Polyneuropathy (BioTRAP)
Related Jobs
Vice President & General Manager, EU North
Vice President & General Manager, EU North
Vice President & General Manager, EU North
Healthcare Representative, Rare Disease
Director, Patient Support Services - Rare Disease
Senior Manager Trade & Distribution
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.